The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

AstraZeneca’s Trixeo recommended for approval in EU by CHMP for the maintenance treatment of asthma: Cambridge, UK Saturday, July 25, 2026, 10:00 Hrs [IST] AstraZeneca’s fixed ...

AstraZeneca (LSE:AZN) has taken another step towards expanding the use of its Trixeo Aerosphere inhaler after the European ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...

AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF), already licensed for the treatment of chronic obstructive pulmonary disease ...

(Corrects paragraph 8 to say propellant offers 99.9% lower global warming potential, not "up to 99.9%", after company clarification) (Reuters) -A panel of the European medicines regulator has ...

AstraZeneca PLC on Friday said Trixeo and an Enhertu combination have been recommended for approval in the EU. The Cambridge, England-based pharmaceutical company said Trixeo has been recommended for ...

(Alliance News) - AstraZeneca PLC on Monday announced that its medicine Trixeo Aerosphere has been approved by the UK Medicines & Healthcare Products Regulatory Agency with "an innovative, ...

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved AstraZeneca's Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF ...

Trixeo/Breztri, is approved in the US for treatment of asthma, with regulatory filings currently under review in other major ...